Theta Burst Stimulation in the Management of Methamphetamine Use Disorder in Indonesia

Methamphetamine use disorder (MUD) remains a major public health concern in Indonesia, with limited effective treatment options and high relapse rates. Theta Burst Stimulation (TBS) has emerged as a promising adjunctive intervention for reducing craving and improving clinical outcomes. This trial aims to evaluate the efficacy and safety of TBS for MUD. A RCT of 20 subjects was conducted to evalute the efficacy and safety of TBS as an adjunctive treatment to CBT in managing MUD.

NCT Number	NCT07399431
Lead Sponsor	Indonesia University
Conditions	Methamphetamine Use Disorder, Theta Burst Stimulation, Transcranial Magnetic Stimulation
Enrollment	22 participants
Start Date	2025-10-19
Primary Completion	2025-11-03 (estimated)
Study Completion	2025-11-05 (estimated)
Updated on ClinicalTrials.gov	2026-02-10